Boston Scientific/BSX
$74.42
-0.17%-
1D1W1MYTD1YMAX
About Boston Scientific
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.
Ticker
BSX
Sector
Healthcare
Trading on
NYSE
Industry
Medical Equipment & Supplies
CEO
Michael Mahoney
Employees
48,000
Headquarters
Marlborough, United States
BSX Metrics
BasicAdvanced
$109B
Market cap
62.16
P/E ratio
$1.20
EPS
0.80
Beta
-
Dividend rate
Price and volume
Market cap
$109B
Beta
0.80414
52-week high
$74.67
52-week low
$48.35
Average daily volume
6.3M
Financial strength
Current ratio
1.665
Quick ratio
1.144
Long term debt to equity
47.847
Total debt to equity
53.292
Enterprise value to free cash flow
53.974
Interest coverage (TTM)
5.43%
Management effectiveness
Return on assets (TTM)
5.09%
Return on equity (TTM)
9.35%
Return on investment (TTM)
5.9%
Valuation
Price to earnings (TTM)
62.163
Price to revenue (TTM)
7.442
Price to book
5.492
Price to free cash flow (TTM)
64.997
Growth
Revenue change (TTM)
12.74%
Earnings per share change (TTM)
104.37%
3-year revenue growth
12.83%
What the Analysts think about BSX
Analyst Ratings
Majority rating from 33 analysts.
Price Targets
Average projection from 29 analysts.
High $90.00
Low $73.00
$74.42
Current price
$82.03
Average price target
BSX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.9B
3.52%
Net income
$494M
-2.18%
Profit margin
12.81%
-5.46%
BSX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.53
$0.50
$0.55
$0.56
-
Expected
$0.49
$0.48
$0.51
$0.51
$0.58
Surprise
8.27%
4.86%
7.37%
9.19%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Boston Scientific stock?
Boston Scientific (BSX) has a market cap of $110B as of May 20, 2024.
What is the P/E ratio for Boston Scientific stock?
The price to earnings (P/E) ratio for Boston Scientific (BSX) stock is 62.33 as of May 20, 2024.
Does Boston Scientific stock pay dividends?
No, Boston Scientific (BSX) stock does not pay dividends to its shareholders as of May 20, 2024.
When is the next Boston Scientific dividend payment date?
Boston Scientific (BSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Boston Scientific?
Boston Scientific (BSX) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Boston Scientific stock price target?
The target price for Boston Scientific (BSX) stock is $82.03, which is 9.89% above the current price of $74.65. This is an average based on projections from 29 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Boston Scientific stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.